A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
Clinical trial NCT06850038 · RECRUITING
Trial details
- NCT number
- NCT06850038
- Sponsor
- Ipsen
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-22
- Primary completion
- 2030-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.